50% OFF
MarketBeat All Access
Get 30 days free. Save 50% your first year.
  •  days
  •  Hours
  •  Minutes
  •  Seconds
×
S&P 500   3,693.23
DOW   29,590.41
QQQ   275.51
Become an Ethical Hacking and Cybercrime Expert
Why I Sued the Gov’t – And What I Recommend Now (Ad)
Judge rejects Justice Dept.'s bid to stop sugar merger
Will Wall Street's Enthusiasm About Datadog Lead To Big Gains?
Why I Sued the Gov’t – And What I Recommend Now (Ad)
Closing prices for crude oil, gold and other commodities
Dow sinks to 2022 low as recession fears roil world markets
One Stock Doubles Your Money, During Crisis? (Ad)
'Crucial' vote could move Italy to right; many might boycott
MarketBeat: Week in Review 9/19 – 9/23
S&P 500   3,693.23
DOW   29,590.41
QQQ   275.51
Become an Ethical Hacking and Cybercrime Expert
Why I Sued the Gov’t – And What I Recommend Now (Ad)
Judge rejects Justice Dept.'s bid to stop sugar merger
Will Wall Street's Enthusiasm About Datadog Lead To Big Gains?
Why I Sued the Gov’t – And What I Recommend Now (Ad)
Closing prices for crude oil, gold and other commodities
Dow sinks to 2022 low as recession fears roil world markets
One Stock Doubles Your Money, During Crisis? (Ad)
'Crucial' vote could move Italy to right; many might boycott
MarketBeat: Week in Review 9/19 – 9/23
S&P 500   3,693.23
DOW   29,590.41
QQQ   275.51
Become an Ethical Hacking and Cybercrime Expert
Why I Sued the Gov’t – And What I Recommend Now (Ad)
Judge rejects Justice Dept.'s bid to stop sugar merger
Will Wall Street's Enthusiasm About Datadog Lead To Big Gains?
Why I Sued the Gov’t – And What I Recommend Now (Ad)
Closing prices for crude oil, gold and other commodities
Dow sinks to 2022 low as recession fears roil world markets
One Stock Doubles Your Money, During Crisis? (Ad)
'Crucial' vote could move Italy to right; many might boycott
MarketBeat: Week in Review 9/19 – 9/23
S&P 500   3,693.23
DOW   29,590.41
QQQ   275.51
Become an Ethical Hacking and Cybercrime Expert
Why I Sued the Gov’t – And What I Recommend Now (Ad)
Judge rejects Justice Dept.'s bid to stop sugar merger
Will Wall Street's Enthusiasm About Datadog Lead To Big Gains?
Why I Sued the Gov’t – And What I Recommend Now (Ad)
Closing prices for crude oil, gold and other commodities
Dow sinks to 2022 low as recession fears roil world markets
One Stock Doubles Your Money, During Crisis? (Ad)
'Crucial' vote could move Italy to right; many might boycott
MarketBeat: Week in Review 9/19 – 9/23
NASDAQ:CTHR

Charles & Colvard, Ltd. - CTHR Stock Forecast, Price & News

$0.98
-0.05 (-4.85%)
(As of 09/23/2022 12:00 AM ET)
Add
Compare
Today's Range
$0.97
$1.02
50-Day Range
$0.98
$1.37
52-Week Range
$0.97
$3.48
Volume
86,481 shs
Average Volume
100,338 shs
Market Capitalization
$29.91 million
P/E Ratio
12.25
Dividend Yield
N/A
Price Target
N/A
CTHR stock logo

About Charles & Colvard, Ltd. (NASDAQ:CTHR) Stock

Charles & Colvard, Ltd. operates as a fine jewelry company in the United States and internationally. The company manufactures, markets, and distributes moissanite jewels and finished moissanite jewelry under the Charles & Colvard Created Moissanite brand; and premium moissanite gemstones under the Forever One brand name. It also markets and distributes lab grown diamonds, and finished jewelry with lab grown diamonds under the Caydia brand. The company sells its products at wholesale prices to distributors, manufacturers, retailers, and designers; and to end-consumers at retail prices through charlesandcolvard.com, third-party online marketplaces, drop-ship, and other e-commerce outlets. Charles & Colvard, Ltd. was founded in 1995 and is headquartered in Morrisville, North Carolina.

Receive CTHR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Charles & Colvard, Ltd. and its competitors with MarketBeat's FREE daily newsletter.

CTHR Stock News Headlines

See More Headlines
Receive CTHR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Charles & Colvard, Ltd. and its competitors with MarketBeat's FREE daily newsletter.

CTHR Company Calendar

Last Earnings
11/04/2021
Today
9/24/2022
Next Earnings (Estimated)
11/03/2022
Fiscal Year End
6/30/2023

Industry, Sector and Symbol

Industry
Jewelry, silverware, & plated ware
Sub-Industry
N/A
Current Symbol
NASDAQ:CTHR
Employees
51
Year Founded
N/A

Profitability

Net Income
$2.37 million
Pretax Margin
6.71%

Debt

Sales & Book Value

Annual Sales
$43.09 million
Cash Flow
$0.09 per share
Book Value
$1.94 per share

Miscellaneous

Free Float
24,781,000
Market Cap
$29.91 million
Optionable
Not Optionable
Beta
0.50

Key Executives

  • Mr. Don O'Connell (Age 56)
    Pres, CEO & Director
    Comp: $373.96k
  • Mr. Clint J. Pete (Age 60)
    CFO & Treasurer
    Comp: $267.03k
  • Mr. John Lane
    VP of Marketing
  • Mr. Randall N. McCullough (Age 70)
    Advisory Consulting













CTHR Stock - Frequently Asked Questions

How have CTHR shares performed in 2022?

Charles & Colvard, Ltd.'s stock was trading at $2.89 on January 1st, 2022. Since then, CTHR stock has decreased by 66.1% and is now trading at $0.9799.
View the best growth stocks for 2022 here
.

When is Charles & Colvard, Ltd.'s next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, November 3rd 2022.
View our CTHR earnings forecast
.

How were Charles & Colvard, Ltd.'s earnings last quarter?

Charles & Colvard, Ltd. (NASDAQ:CTHR) posted its earnings results on Thursday, November, 4th. The company reported $0.03 EPS for the quarter, topping analysts' consensus estimates of $0.02 by $0.01. The firm had revenue of $10.28 million for the quarter, compared to analyst estimates of $9.20 million. Charles & Colvard, Ltd. had a net margin of 5.51% and a trailing twelve-month return on equity of 4.05%. During the same period last year, the business posted $0.03 earnings per share.

What other stocks do shareholders of Charles & Colvard, Ltd. own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Charles & Colvard, Ltd. investors own include Matinas BioPharma (MTNB), ADMA Biologics (ADMA), Golar LNG Partners (GMLP), Novan (NOVN), OrganiGram (OGI), Pennsylvania Real Estate Investment Trust (PEI), Bionano Genomics (BNGO), Gran Tierra Energy (GTE), Zosano Pharma (ZSAN) and Aeterna Zentaris (AEZS).

What is Charles & Colvard, Ltd.'s stock symbol?

Charles & Colvard, Ltd. trades on the NASDAQ under the ticker symbol "CTHR."

Who are Charles & Colvard, Ltd.'s major shareholders?

Charles & Colvard, Ltd.'s stock is owned by a number of retail and institutional investors. Top institutional shareholders include Renaissance Technologies LLC (5.68%), Victory Capital Management Inc. (0.97%), Ronald Blue Trust Inc. (0.16%), Cerity Partners LLC (0.08%), Founders Capital Management (0.07%) and Concourse Financial Group Securities Inc. (0.00%). Insiders that own company stock include Clint J Pete, Don O'connell, Neal I Goldman and Ollin B Sykes.
View institutional ownership trends
.

How do I buy shares of Charles & Colvard, Ltd.?

Shares of CTHR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Charles & Colvard, Ltd.'s stock price today?

One share of CTHR stock can currently be purchased for approximately $0.98.

How much money does Charles & Colvard, Ltd. make?

Charles & Colvard, Ltd. (NASDAQ:CTHR) has a market capitalization of $29.90 million and generates $43.09 million in revenue each year. The company earns $2.37 million in net income (profit) each year or $0.08 on an earnings per share basis.

How can I contact Charles & Colvard, Ltd.?

Charles & Colvard, Ltd.'s mailing address is 170 SOUTHPORT DRIVE, MORRISVILLE NC, 27560. The official website for the company is www.charlesandcolvard.com. The company can be reached via phone at (919) 468-0399, via email at ir@charlesandcolvard.com, or via fax at 919-468-0486.

This page (NASDAQ:CTHR) was last updated on 9/24/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.